Growth momentum Target enterprise life sciences firms seeking scalable data management and integration solutions. Anju Software has a foothold with mid-sized to large pharma, CROs, and medical device companies, plus recent funding and ownership under Valsoft signaling growth resources to pursue larger deals and additional modules.

Product expansion Leverage recent feature launches such as Feasibility Flex and MA Knowledge to upsell capabilities around trial feasibility analytics and mobile field information. Position as enhancements to TA Scan and trial operations to improve feasibility accuracy and field force efficiency.

Strategic partnerships Explore co-sell or integration partnerships with Vita Global Sciences and other life science service providers. Joint offerings could expand deployment across clinical research, medical affairs, and data science workflows, increasing addressable market and reference opportunities.

Industry events Capitalize on active event participation (SCOPE Summit, DIA Global Meeting) to accelerate lead generation. Use speaking slots and demos to showcase data-driven decision making, third-party system integrations, and customer-first implementations to attract potential buyers evaluating information management platforms.

Financials and scale With revenue in the 50-100 million range and recent acquisition by Valsoft, emphasize stability and long-term support for mission-critical software. Position as a reliable partner for customers planning multi-year deployments and platform expansions, with potential for bundled solutions.